Table 1 Patient characteristics, stratified by glucose tolerance (N = 97)
From: Association between serum S100A11 levels and glucose metabolism in diabetic process
Item | Total patients (N = 97) | Normal (N = 33) | IGT (N = 26) | Diabetes (N = 38) | P-value |
|---|---|---|---|---|---|
S100A11(ng/mL) | 5.82 (2.75) | 4.04 (1.90) | 6.43 (1.76) | 6.94 (3.17) | < 0.001 |
Male | 41 (42.27%) | 13 (39.39%) | 11 (42.31%) | 17 (44.74%) | 0.902 |
AGE (years) | 49.77 (12.50) | 47.48 (12.21) | 50.58 (15.99) | 51.21 (9.81) | 0.323 |
BMI (kg/m2) | 25.46 (3.93) | 25.80 (4.00) | 24.93 (2.79) | 0.611 | 0.565 |
WHR | 0.90 (0.07) | 0.88 (0.07) | 0.90 (0.08) | 0.91 (0.06) | 0.067 |
HbA1c (%) | 6.88 (1.99) | 5.73 (0.71) | 6.01 (0.58) | 8.47 (2.30) | < 0.001 |
FPG (mmol/L) | 7.33 (3.03) | 5.36 (0.45) | 5.91 (0.56) | 10.02 (3.34) | < 0.001 |
0.5hPPG (mmol/L) | 12.28 (4.20) | 8.97 (1.42) | 10.89 (1.67) | 16.11 (3.98) | < 0.001 |
FPI (uU/mL) | 9.41 (5.69–15.87) | 8.18 (6.39–12.03) | 10.73 (6.77–18.59) | 11.41(5.31–15.82) | 0.515 |
0.5hPPI (uU/mL) | 43.86 (22.35–74.47) | 66.78 (41.98–92.69) | 46.72 (36.27–75.53) | 20.44(12.55–44.80) | < 0.001 |
HOMA-IR | 2.86 (1.78–5.07) | 1.94 (1.44–2.86) | 2.77 (1.76–4.58) | 4.07 (2.36–6.70) | 0.013 |
HOMA-β | 72.71 (32.66–111.90) | 90.91 (70.17–122.79) | 87.52 (53.64–137.19) | 33.63 (22.02–69.04) | 0.002 |
ISI (the liver) | 6.30 (3.55–10.14) | 9.28 (6.30–12.48) | 6.55 (3.93–10.26) | 4.43 (2.69–7.66) | 0.002 |
ISI (the body) | 0.55 (0.25–1.79) | 0.36 (0.23–0.82) | 0.42 (0.19–1.14) | 1.03 (0.40–3.60) | 0.041 |
CIR | 58.12 (20.15–138.10) | 141.56 (98.40–302.99) | 73.42 (43.28–114.81) | 14.81 (6.08–31.90) | < 0.001 |
DIo (the liver) | 391.99 (102.55–1076.93) | 1300.98 (911.61–2333.22) | 443.40 (217.79–656.85) | 56.50 (24.35–129.69) | < 0.001 |
DIo (the body) | 26.57 (13.48–66.83) | 66.83 (42.11–102.18) | 31.65 (21.43–57.62) | 14.12 (7.59–21.82) | < 0.001 |